Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients: a Phase IV, Double-blind, Placebo-controlled Study.

NCT02146534 is registered in ClinicalTrials.gov with Clinique Neuro-Outaouais as lead sponsor.

NCT NCT02146534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02146534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolonged-release Fampridine as Adjunct Therapy to Active Motor Training in MS Patients: a Phase IV, Double-blind, Placebo-controlled Study.
Lead sponsor
Clinique Neuro-Outaouais
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2013
Completion date
January 31, 2016
Enrollment
44 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis